Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions

Niki Katsiki 12 Dionyssiou St, Thessaloniki, 546 34, Greece; Correspondence[email protected]

Vasilios G. AthyrosSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece;

Dimitri P. MikhailidisDepartment of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), Pond Street, LondonNW3 2QG, UK

"Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions." Current Medical Research and Opinion, 32(9), pp. 1513–1514

Transparency

Declaration of funding

This letter was written independently. The authors did not receive financial or professional help with the preparation of the manuscript.

Declaration of financial/other relationships

N.K. has disclosed that she has given talks, attended conferences and participated in trials sponsored by Amgen, Astra Zeneca, MSD, Novo Nordisk, Novartis and Sanofi. V.G.A. has disclosed that he has given talks, attended conferences and participated in trials sponsored by Amgen, Sanofi, MSD, Lilly and Angelini. D.P.M. has disclosed that he has given talks and attended conferences sponsored by MSD, AstraZeneca and Libytec.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions

Declaration of funding

Declaration of financial/other relationships

Information for

Open access

Opportunities

Help and information

Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions

Transparency

Declaration of funding

Declaration of financial/other relationships

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature